Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation

NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer discovery Vol. 12; no. 4; p. 1152
Main Authors:	Chandra, Bappaditya, Michmerhuizen, Nicole L, Shirnekhi, Hazheen K, Tripathi, Swarnendu, Pioso, Brittany J, Baggett, David W, Mitrea, Diana M, Iacobucci, Ilaria, White, Michael R, Chen, Jingjing, Park, Cheon-Gil, Wu, Huiyun, Pounds, Stanley, Medyukhina, Anna, Khairy, Khaled, Gao, Qingsong, Qu, Chunxu, Abdelhamed, Sherif, Gorman, Scott D, Bawa, Simranjot, Maslanka, Carolyn, Kinger, Swati, Dogra, Priyanka, Ferrolino, Mylene C, Di Giacomo, Danika, Mecucci, Cristina, Klco, Jeffery M, Mullighan, Charles G, Kriwacki, Richard W
Format:	Journal Article
Language:	English
Published:	United States 01.04.2022
Subjects:	Carcinogenesis Cell Nucleus Child Homeodomain Proteins - genetics Homeodomain Proteins - metabolism Humans Leukemia - genetics Nuclear Pore Complex Proteins - genetics Oncogene Proteins, Fusion - genetics Oncogene Proteins, Fusion - metabolism Retinoblastoma-Binding Protein 2
ISSN:	2159-8290, 2159-8290
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9), retains a DNA-binding homeodomain, whereas others harbor other types of DNA- or chromatin-binding domains. NUP98 FOs have long been known to form puncta, but long-standing questions are how nuclear puncta form and how they drive leukemogenesis. Here we studied NHA9 condensates and show that homotypic interactions and different types of heterotypic interactions are required to form nuclear puncta, which are associated with aberrant transcriptional activity and transformation of hematopoietic stem and progenitor cells. We also show that three additional leukemia-associated NUP98 FOs (NUP98-PRRX1, NUP98-KDM5A, and NUP98-LNP1) form nuclear puncta and transform hematopoietic cells. These findings indicate that LLPS is critical for leukemogenesis by NUP98 FOs. We show that homotypic and heterotypic mechanisms of LLPS control NUP98-HOXA9 puncta formation, modulating transcriptional activity and transforming hematopoietic cells. Importantly, these mechanisms are generalizable to other NUP98 FOs that share similar domain structures. These findings address long-standing questions on how nuclear puncta form and their link to leukemogenesis. This article is highlighted in the In This Issue feature, p. 873.
AbstractList	NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9), retains a DNA-binding homeodomain, whereas others harbor other types of DNA- or chromatin-binding domains. NUP98 FOs have long been known to form puncta, but long-standing questions are how nuclear puncta form and how they drive leukemogenesis. Here we studied NHA9 condensates and show that homotypic interactions and different types of heterotypic interactions are required to form nuclear puncta, which are associated with aberrant transcriptional activity and transformation of hematopoietic stem and progenitor cells. We also show that three additional leukemia-associated NUP98 FOs (NUP98-PRRX1, NUP98-KDM5A, and NUP98-LNP1) form nuclear puncta and transform hematopoietic cells. These findings indicate that LLPS is critical for leukemogenesis by NUP98 FOs.NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9), retains a DNA-binding homeodomain, whereas others harbor other types of DNA- or chromatin-binding domains. NUP98 FOs have long been known to form puncta, but long-standing questions are how nuclear puncta form and how they drive leukemogenesis. Here we studied NHA9 condensates and show that homotypic interactions and different types of heterotypic interactions are required to form nuclear puncta, which are associated with aberrant transcriptional activity and transformation of hematopoietic stem and progenitor cells. We also show that three additional leukemia-associated NUP98 FOs (NUP98-PRRX1, NUP98-KDM5A, and NUP98-LNP1) form nuclear puncta and transform hematopoietic cells. These findings indicate that LLPS is critical for leukemogenesis by NUP98 FOs.We show that homotypic and heterotypic mechanisms of LLPS control NUP98-HOXA9 puncta formation, modulating transcriptional activity and transforming hematopoietic cells. Importantly, these mechanisms are generalizable to other NUP98 FOs that share similar domain structures. These findings address long-standing questions on how nuclear puncta form and their link to leukemogenesis. This article is highlighted in the In This Issue feature, p. 873.SIGNIFICANCEWe show that homotypic and heterotypic mechanisms of LLPS control NUP98-HOXA9 puncta formation, modulating transcriptional activity and transforming hematopoietic cells. Importantly, these mechanisms are generalizable to other NUP98 FOs that share similar domain structures. These findings address long-standing questions on how nuclear puncta form and their link to leukemogenesis. This article is highlighted in the In This Issue feature, p. 873. NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered region from NUP98 that is prone to liquid-liquid phase separation (LLPS) in vitro. A predominant class of NUP98 FOs, including NUP98-HOXA9 (NHA9), retains a DNA-binding homeodomain, whereas others harbor other types of DNA- or chromatin-binding domains. NUP98 FOs have long been known to form puncta, but long-standing questions are how nuclear puncta form and how they drive leukemogenesis. Here we studied NHA9 condensates and show that homotypic interactions and different types of heterotypic interactions are required to form nuclear puncta, which are associated with aberrant transcriptional activity and transformation of hematopoietic stem and progenitor cells. We also show that three additional leukemia-associated NUP98 FOs (NUP98-PRRX1, NUP98-KDM5A, and NUP98-LNP1) form nuclear puncta and transform hematopoietic cells. These findings indicate that LLPS is critical for leukemogenesis by NUP98 FOs. We show that homotypic and heterotypic mechanisms of LLPS control NUP98-HOXA9 puncta formation, modulating transcriptional activity and transforming hematopoietic cells. Importantly, these mechanisms are generalizable to other NUP98 FOs that share similar domain structures. These findings address long-standing questions on how nuclear puncta form and their link to leukemogenesis. This article is highlighted in the In This Issue feature, p. 873.
Author	Pounds, Stanley Park, Cheon-Gil White, Michael R Michmerhuizen, Nicole L Qu, Chunxu Chen, Jingjing Mecucci, Cristina Dogra, Priyanka Iacobucci, Ilaria Khairy, Khaled Wu, Huiyun Baggett, David W Di Giacomo, Danika Klco, Jeffery M Maslanka, Carolyn Medyukhina, Anna Gao, Qingsong Abdelhamed, Sherif Kriwacki, Richard W Pioso, Brittany J Mitrea, Diana M Shirnekhi, Hazheen K Tripathi, Swarnendu Kinger, Swati Ferrolino, Mylene C Gorman, Scott D Chandra, Bappaditya Bawa, Simranjot Mullighan, Charles G
Author_xml	– sequence: 1 givenname: Bappaditya surname: Chandra fullname: Chandra, Bappaditya organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 2 givenname: Nicole L orcidid: 0000-0002-9960-5119 surname: Michmerhuizen fullname: Michmerhuizen, Nicole L organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 3 givenname: Hazheen K surname: Shirnekhi fullname: Shirnekhi, Hazheen K organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 4 givenname: Swarnendu surname: Tripathi fullname: Tripathi, Swarnendu organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 5 givenname: Brittany J orcidid: 0000-0002-0123-8905 surname: Pioso fullname: Pioso, Brittany J organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 6 givenname: David W surname: Baggett fullname: Baggett, David W organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 7 givenname: Diana M surname: Mitrea fullname: Mitrea, Diana M organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 8 givenname: Ilaria orcidid: 0000-0003-2008-1365 surname: Iacobucci fullname: Iacobucci, Ilaria organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 9 givenname: Michael R surname: White fullname: White, Michael R organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 10 givenname: Jingjing orcidid: 0000-0003-4179-0371 surname: Chen fullname: Chen, Jingjing organization: Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 11 givenname: Cheon-Gil surname: Park fullname: Park, Cheon-Gil organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 12 givenname: Huiyun surname: Wu fullname: Wu, Huiyun organization: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 13 givenname: Stanley surname: Pounds fullname: Pounds, Stanley organization: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 14 givenname: Anna orcidid: 0000-0001-5268-713X surname: Medyukhina fullname: Medyukhina, Anna organization: Center for Bioimage Informatics, St. Jude Children's Research Hospital Memphis, Tennessee – sequence: 15 givenname: Khaled orcidid: 0000-0002-9274-5928 surname: Khairy fullname: Khairy, Khaled organization: Center for Bioimage Informatics, St. Jude Children's Research Hospital Memphis, Tennessee – sequence: 16 givenname: Qingsong surname: Gao fullname: Gao, Qingsong organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 17 givenname: Chunxu surname: Qu fullname: Qu, Chunxu organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 18 givenname: Sherif orcidid: 0000-0002-3319-2403 surname: Abdelhamed fullname: Abdelhamed, Sherif organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 19 givenname: Scott D surname: Gorman fullname: Gorman, Scott D organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 20 givenname: Simranjot surname: Bawa fullname: Bawa, Simranjot organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 21 givenname: Carolyn surname: Maslanka fullname: Maslanka, Carolyn organization: Rhodes College, Memphis, Tennessee – sequence: 22 givenname: Swati orcidid: 0000-0002-2053-0944 surname: Kinger fullname: Kinger, Swati organization: Rhodes College, Memphis, Tennessee – sequence: 23 givenname: Priyanka surname: Dogra fullname: Dogra, Priyanka organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 24 givenname: Mylene C orcidid: 0000-0002-9693-8401 surname: Ferrolino fullname: Ferrolino, Mylene C organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 25 givenname: Danika surname: Di Giacomo fullname: Di Giacomo, Danika organization: Department of Medicine and Surgery, University of Perugia, Perugia, Italy – sequence: 26 givenname: Cristina surname: Mecucci fullname: Mecucci, Cristina organization: Department of Medicine and Surgery, University of Perugia, Perugia, Italy – sequence: 27 givenname: Jeffery M orcidid: 0000-0003-2961-6960 surname: Klco fullname: Klco, Jeffery M organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 28 givenname: Charles G orcidid: 0000-0002-1871-1850 surname: Mullighan fullname: Mullighan, Charles G organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee – sequence: 29 givenname: Richard W orcidid: 0000-0002-9798-6018 surname: Kriwacki fullname: Kriwacki, Richard W organization: Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Sciences Center, Memphis, Tennessee
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34903620$$D View this record in MEDLINE/PubMed
BookMark	eNpNj81OwzAQhC1UREvpGyCUI5fAruPE9hEVyo8KrUR7jhxnLQKNU-LkwNtToCDmsqPRt6udYzbwjSfGThEuEFN1yTHVseIaLqbXMccYMikO2OgvHvzzQzYJ4RV2ElqkII_YMBEakozDiD0sX0yg6Jm2pjVd1fjokcrKdBSip_VSq2jWh6904W2zbZuOKh_NqX-jurLRqjU-uKatvzdP2KEzm0CT_Ryz9exmNb2L54vb--nVPLZCii7mSovMOV5II1FI1NIZg1ZbKzlhiZAocklSpGiMLJV2stDKpqAzW0IhBB-z85-7u3_eewpdXlfB0mZjPDV9yHmGAFILhB16tkf7oqYy37ZVbdqP_Lc__wQ4Il9Q
CitedBy_id	crossref_primary_10_1038_s43018_024_00777_2 crossref_primary_10_1080_14728222_2024_2443577 crossref_primary_10_1038_s41573_022_00505_4 crossref_primary_10_1016_j_celrep_2025_115539 crossref_primary_10_1038_s41580_023_00673_0 crossref_primary_10_1063_5_0137008 crossref_primary_10_1186_s13072_023_00502_w crossref_primary_10_1038_s41594_024_01322_6 crossref_primary_10_1016_j_molcel_2024_12_026 crossref_primary_10_1038_s41598_023_39102_9 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2025059014 crossref_primary_10_1093_procel_pwad013 crossref_primary_10_1016_j_cell_2025_04_002 crossref_primary_10_1097_HS9_0000000000000923 crossref_primary_10_1186_s13046_022_02248_x crossref_primary_10_1073_pnas_2219589120 crossref_primary_10_1016_j_devcel_2022_06_010 crossref_primary_10_1158_2159_8290_CD_23_0876 crossref_primary_10_1038_s41577_025_01130_z crossref_primary_10_1080_17501911_2024_2447807 crossref_primary_10_1002_mco2_223 crossref_primary_10_1038_s41556_025_01745_3 crossref_primary_10_15252_embj_2022112987 crossref_primary_10_1016_j_gde_2023_102136 crossref_primary_10_1007_s00018_023_05068_0 crossref_primary_10_1038_s41392_024_02013_w crossref_primary_10_1186_s13045_023_01522_5 crossref_primary_10_1016_j_jmb_2025_169398 crossref_primary_10_1093_nar_gkac1158 crossref_primary_10_1096_fj_202300216R crossref_primary_10_1002_cam4_7445 crossref_primary_10_1038_s41556_024_01420_z crossref_primary_10_1016_j_molcel_2025_06_008 crossref_primary_10_1097_HS9_0000000000000935 crossref_primary_10_1016_j_molcel_2025_05_012 crossref_primary_10_1152_physiol_00013_2024 crossref_primary_10_3390_ijms26115156 crossref_primary_10_3389_fimmu_2025_1604015 crossref_primary_10_1158_2159_8290_CD_21_1605 crossref_primary_10_1002_adma_202510115 crossref_primary_10_1186_s12943_024_02002_1 crossref_primary_10_1016_j_celrep_2024_114901 crossref_primary_10_3390_cancers14133270 crossref_primary_10_1038_s41389_024_00539_w crossref_primary_10_1172_JCI184743 crossref_primary_10_1002_hem3_70013 crossref_primary_10_1016_j_tcb_2022_03_005 crossref_primary_10_1016_j_gde_2024_102203 crossref_primary_10_1042_BST20220494 crossref_primary_10_1016_j_tcb_2022_11_009 crossref_primary_10_1038_s41557_022_01035_7 crossref_primary_10_1038_s41587_023_01955_w crossref_primary_10_3390_cancers15112942 crossref_primary_10_1007_s00432_024_05881_5 crossref_primary_10_1016_j_molcel_2024_08_021 crossref_primary_10_1146_annurev_cancerbio_060324_114306 crossref_primary_10_1016_j_exphem_2025_104791 crossref_primary_10_1038_s41467_024_48194_4 crossref_primary_10_1007_s00441_025_03974_2 crossref_primary_10_1038_s41467_023_41655_2 crossref_primary_10_1016_j_sbi_2023_102742 crossref_primary_10_1038_s41467_025_59930_9 crossref_primary_10_3390_cancers14235971 crossref_primary_10_1038_s41586_025_09141_5 crossref_primary_10_1155_2022_7165387 crossref_primary_10_1016_j_bbcan_2024_189206 crossref_primary_10_1172_JCI191355 crossref_primary_10_1016_j_celrep_2023_112884 crossref_primary_10_1038_s41556_025_01746_2 crossref_primary_10_1002_1873_3468_14728 crossref_primary_10_1016_j_jbc_2025_108423 crossref_primary_10_1038_s41580_024_00789_x crossref_primary_10_1002_prot_70009 crossref_primary_10_1016_j_canlet_2025_217449 crossref_primary_10_5582_bst_2022_01449 crossref_primary_10_3389_fonc_2025_1540427 crossref_primary_10_3390_biom12101480 crossref_primary_10_1016_j_molcel_2022_05_018 crossref_primary_10_1093_bib_bbad362 crossref_primary_10_1016_j_biochi_2024_05_007 crossref_primary_10_1038_s12276_023_00934_0 crossref_primary_10_1038_s41392_023_01649_4 crossref_primary_10_1182_blood_2022016889 crossref_primary_10_1186_s12943_025_02428_1 crossref_primary_10_1016_j_heliyon_2024_e34035 crossref_primary_10_1016_j_molcel_2022_09_034 crossref_primary_10_1073_pnas_2310430121 crossref_primary_10_1007_s11427_024_2661_3 crossref_primary_10_1093_nar_gkaf056 crossref_primary_10_1016_j_tips_2022_07_001
ContentType	Journal Article
Copyright	2021 The Authors; Published by the American Association for Cancer Research.
Copyright_xml	– notice: 2021 The Authors; Published by the American Association for Cancer Research.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1158/2159-8290.CD-21-0674
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	2159-8290
ExternalDocumentID	34903620
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NCI NIH HHS grantid: F32 CA261011 – fundername: NCI NIH HHS grantid: R35 CA197695 – fundername: NCI NIH HHS grantid: U54 CA243124 – fundername: NCI NIH HHS grantid: P30 CA021765 – fundername: NIGMS NIH HHS grantid: F32 GM143847 – fundername: NCI NIH HHS grantid: T32 CA236748 – fundername: NCI NIH HHS grantid: R01 CA246125
GroupedDBID	--- 53G 5VS ADBBV ADCOW AENEX AFHIN AFUMD ALMA_UNASSIGNED_HOLDINGS BR6 BTFSW CGR CUY CVF EBS ECM EIF EJD KQ8 NPM OK1 RCR RHI 7X8
ID	FETCH-LOGICAL-c474t-28946ff2b7a7147197faa1c9cc72e1d1038ef33b51aa7d89f7b98c5096cd0b442
IEDL.DBID	7X8
ISICitedReferencesCount	117
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000798853200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2159-8290
IngestDate	Fri Sep 05 06:48:00 EDT 2025 Thu Apr 03 06:57:22 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	false
IsScholarly	true
Issue	4
Language	English
License	2021 The Authors; Published by the American Association for Cancer Research.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c474t-28946ff2b7a7147197faa1c9cc72e1d1038ef33b51aa7d89f7b98c5096cd0b442
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0002-2053-0944 0000-0002-3319-2403 0000-0002-9960-5119 0000-0002-9693-8401 0000-0003-2008-1365 0000-0003-4179-0371 0000-0001-5268-713X 0000-0002-0123-8905 0000-0003-2961-6960 0000-0002-9798-6018 0000-0002-1871-1850 0000-0002-9274-5928
OpenAccessLink	https://aacrjournals.org/cancerdiscovery/article-pdf/12/4/1152/3200648/1152.pdf
PMID	34903620
PQID	2610079410
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2610079410 pubmed_primary_34903620
PublicationCentury	2000
PublicationDate	2022-04-01
PublicationDateYYYYMMDD	2022-04-01
PublicationDate_xml	– month: 04 year: 2022 text: 2022-04-01 day: 01
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Cancer discovery
PublicationTitleAlternate	Cancer Discov
PublicationYear	2022
SSID	ssj0000494507
Score	2.6301467
Snippet	NUP98 fusion oncoproteins (FO) are drivers in pediatric leukemias and many transform hematopoietic cells. Most NUP98 FOs harbor an intrinsically disordered...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1152
SubjectTerms	Carcinogenesis Cell Nucleus Child Homeodomain Proteins - genetics Homeodomain Proteins - metabolism Humans Leukemia - genetics Nuclear Pore Complex Proteins - genetics Oncogene Proteins, Fusion - genetics Oncogene Proteins, Fusion - metabolism Retinoblastoma-Binding Protein 2
Title	Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
URI	https://www.ncbi.nlm.nih.gov/pubmed/34903620 https://www.proquest.com/docview/2610079410
Volume	12
WOSCitedRecordID	wos000798853200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Ivgat7bpkjyJqENkqwU32NtI0hSHkE67-fvNSbvpiyD40odCoJyenO9cv4PQFeyz5UrmJDQBlBk7EVEyE0TrTIfURRRB7klceyxJ-Ggk0jrhVtZtlQub6A11VmjIkbecp-_gTNCgfTN9J7A1Cqqr9QqNVdSInCsDWs1GfJljAe6T2E9MO2ATBGqG9fRcEPPW8t313T0Jof8Huv5-8zM93nS3__ulO2ir9jTxbaUau2jF2D200a9r6fvoKX11CIZfTMX-XVjc92s7TImTYSo47s4hk4afrS48m8PE4p6Zv0E3PR788HcLe4CG3YfB3SOpNysQTRmdERdl0U6eh4pJFjh4EiyXMtBCa-b-WQak6SaPIhUHUrKMi5wpwTUwxeisrSgND9GaLaw5RjgLTSilswvGxTZKQ24yUFpHPIuo4HHcRJcLKY2d5kI5QlpTzMvxt5ya6KgS9XhaUWyM3VmA1vbJH06fos0QZhJ8O80ZauTu3ppztK4_Z5Py48KrhHsmaf8Lf0y-EA
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+Separation+Mediates+NUP98+Fusion+Oncoprotein+Leukemic+Transformation&rft.jtitle=Cancer+discovery&rft.au=Chandra%2C+Bappaditya&rft.au=Michmerhuizen%2C+Nicole+L&rft.au=Shirnekhi%2C+Hazheen+K&rft.au=Tripathi%2C+Swarnendu&rft.date=2022-04-01&rft.eissn=2159-8290&rft.volume=12&rft.issue=4&rft.spage=1152&rft_id=info:doi/10.1158%2F2159-8290.CD-21-0674&rft_id=info%3Apmid%2F34903620&rft_id=info%3Apmid%2F34903620&rft.externalDocID=34903620
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2159-8290&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2159-8290&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2159-8290&client=summon